Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Croce

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
BMJ Open|August 3, 2017
Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in ItalyUmberto Restelli, Gabriella Saibene, Patrizia Nardulli, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 7, 2014
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health ServiceUmberto Restelli, Massimo Andreoni, Andrea Antinori, et al.
Insights Into Imaging|February 25, 2014
Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessmentGiovanni Mauri, Emanuele Porazzi, Luca Cova, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 13, 2018
A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?Tiziana Galli, Paolo Mirata, Emanuela Foglia, et al.
Journal of Preventive Medicine and Hygiene|November 5, 2020
The impact of PrEP: results from a multicenter Health Technology Assessment into the Italian settingLucrezia Ferrario, Emanuela Foglia, Elisabetta Garagiola, et al.
The New Microbiologica|September 3, 2014
Health technology assessment in the HIV setting: the case of monotherapyUmberto Restelli, Davide Croce, Emanuele Porazzi, et al.
International Journal of Technology Assessment in Health Care|June 6, 2017
TECHNOLOGY ASSESSMENT IN HOSPITALS: LESSONS LEARNED FROM AN EMPIRICAL EXPERIMENTEmanuela Foglia, Emanuele Lettieri, Lucrezia Ferrario, et al.
BMJ Open|September 14, 2019
Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysisUmberto Restelli, Marzia Bonfanti, Davide Croce, et al.
Clinical Drug Investigation|July 11, 2020
Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XRUmberto Restelli, Manuel García-Goñi, Michal Lew-Starowicz, et al.
Health Economics Review|August 30, 2020
Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practiceElisabetta Garagiola, Emanuela Foglia, Lucrezia Ferrario, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
BMJ Open|August 3, 2017
Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in ItalyUmberto Restelli, Gabriella Saibene, Patrizia Nardulli, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 7, 2014
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health ServiceUmberto Restelli, Massimo Andreoni, Andrea Antinori, et al.
Insights Into Imaging|February 25, 2014
Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessmentGiovanni Mauri, Emanuele Porazzi, Luca Cova, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 13, 2018
A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?Tiziana Galli, Paolo Mirata, Emanuela Foglia, et al.
Journal of Preventive Medicine and Hygiene|November 5, 2020
The impact of PrEP: results from a multicenter Health Technology Assessment into the Italian settingLucrezia Ferrario, Emanuela Foglia, Elisabetta Garagiola, et al.
The New Microbiologica|September 3, 2014
Health technology assessment in the HIV setting: the case of monotherapyUmberto Restelli, Davide Croce, Emanuele Porazzi, et al.
International Journal of Technology Assessment in Health Care|June 6, 2017
TECHNOLOGY ASSESSMENT IN HOSPITALS: LESSONS LEARNED FROM AN EMPIRICAL EXPERIMENTEmanuela Foglia, Emanuele Lettieri, Lucrezia Ferrario, et al.
BMJ Open|September 14, 2019
Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysisUmberto Restelli, Marzia Bonfanti, Davide Croce, et al.
Clinical Drug Investigation|July 11, 2020
Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XRUmberto Restelli, Manuel García-Goñi, Michal Lew-Starowicz, et al.
Health Economics Review|August 30, 2020
Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practiceElisabetta Garagiola, Emanuela Foglia, Lucrezia Ferrario, et al.
Pageof 6